COLEMAN FARR: Open Payments
NPI 1316370356 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 18 payments from 8 companies in 2025. Trend: 2023 $334 · 2024 $231 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| Pulmonx Corporation | 4 | $72 |
| Mallinckrodt Hospital Products Inc. | 3 | $65 |
| Merck Sharp & Dohme LLC | 3 | $57 |
| ABBVIE INC. | 3 | $51 |
| La Jolla Pharmaceutical Company | 2 | $47 |
| Ambu Inc. | 1 | $37 |
| GENZYME CORPORATION | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: CHARTIS CATHETER, ACTHAR, ZERBAXA, GIAPREZA, EMBLAVEO, DUPIXENT, TEFLARO, FASENRA.
Industry payments across MS — which companies pay providers there.
